The study of cardiotoxicity of hydroxychloroquine and azithromycine combination in hospitalized patients with COVID-19

The study of cardiotoxicity of hydroxychloroquine and azithromycine combination in hospitalized patients with COVID-19

Hydroxychloroquine (HCH) is included in guidelines for treatment of novel coronavirus infection (COVID-19). Data on increased risk of cardiovascular complications when using it have been published. Aim. To evaluate the safety and tolerability of HCH and azithromycine (AZM) combination for the treatm...

Full description

Bibliographic Details
Main Authors:	Yu. N. Belenkov, I. V. Menshikova, I. S. Ilgisonis, Yu. I. Naimann, Yu. V. Pak, I. R. Kolosova, A. S. Rakovskaya
Format:	Article
Language:	Russian
Published:	Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) 2020-12-01
Series:	Сеченовский вестник
Subjects:	novel coronavirus infection covid-19 hydroxychloroquine cardiovascular complications
Online Access:	https://www.sechenovmedj.com/jour/article/view/239

Similar Items

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
by: Samia Arshad, et al.
Published: (2020-08-01)

Hydroxychloroquine and azithromycin use in COVID-19 era and cardiovascular concerns: Current perspective
by: Aditya Kapoor, et al.
Published: (2021-01-01)

Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance
by: R. Choudhary, et al.
Published: (2020-05-01)

Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
by: Elisa Baranski Lamback, et al.
Published: (2021-03-01)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)

Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)—protocol of randomised controlled trial AZIQUINE-ICU
by: František Duška, et al.
Published: (2020-07-01)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
by: Filippo Albani, et al.
Published: (2020-08-01)

Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis
by: Pravash Budhathoki, et al.
Published: (2021-04-01)

The role of hydroxychloroquine in COVID-19: Where do we stand?
by: Ranjit Mohan Anjana, et al.
Published: (2020-01-01)

COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020
by: François Bénézit, et al.
Published: (2020-10-01)

Early hydroxychloroquine and azithromycin as combined therapy for COVID-19: a case series
by: Siswanto Siswanto, et al.
Published: (2020-06-01)

The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article
by: Shagun B Shah, et al.
Published: (2020-01-01)

The impact of hydroxychloroquine–azithromycin combination on Tpeak‐to‐end and Tpeak‐to‐end/QT ratio during a short treatment course
by: Nijad Bakhshaliyev, et al.
Published: (2021-07-01)

Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al
by: Mondher Toumi, et al.
Published: (2020-01-01)

Effects of cardiac toxicity of combination therapy with hydroxychloroquine and azithromycin in COVID-19 patients
by: Usha Yendrapalli, et al.
Published: (2021-11-01)

Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
by: Chunfeng Li, et al.
Published: (2020-08-01)

Hydroxychloroquine and chloroquine in prophylaxis and treatment of COVID-19: What is known?
by: Pathiyil Ravi Shankar, et al.
Published: (2021-01-01)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
by: Nobuaki Mori, et al.
Published: (2021-02-01)

Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
by: Bianza Moise Bakadia, et al.
Published: (2021-01-01)

Proarrhythmia assessment in treatment with hydroxychloroquine and azithromycin hospitalized elderly COVID-19 patients - our experience
by: Raffaele Costa, et al.
Published: (2021-06-01)

Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
by: Matthieu MILLION, et al.
Published: (2021-09-01)

Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use
by: Yan Chen, et al.
Published: (2020-07-01)

Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19
by: S. Saqrane, et al.
Published: (2020-05-01)

Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review
by: Mudit Agarwal, et al.
Published: (2020-12-01)

Impact of Hydroxychloroquine on Mortality in Hospitalized Patients with COVID-19: Systematic Review and Meta-Analysis
by: Thomas S. Hong, et al.
Published: (2020-11-01)

No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19
by: Kenneth Sands, et al.
Published: (2021-03-01)

Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases
by: Yanting Yu, et al.
Published: (2021-04-01)

The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
by: Elangovan Manivannan, et al.
Published: (2021-05-01)

Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses
by: Peng Liu, et al.
Published: (2020-01-01)

Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan
by: Kazimieras Maneikis, et al.
Published: (2021-02-01)

Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
by: Faizan Mazhar, et al.
Published: (2020-12-01)

Doxycycline as a potential partner of COVID-19 therapies
by: Alexandre E. Malek, et al.
Published: (2020-01-01)

The use of Hydroxychloroquine in the Treatment of COVID-19
by: Kamer TECEN-YÜCEL, et al.
Published: (2020-09-01)

Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial
by: Christine Johnston, et al.
Published: (2021-03-01)

Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review
by: Kome Gbinigie, et al.
Published: (2020-04-01)

Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis
by: Atiya R Faruqui, et al.
Published: (2021-01-01)

Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19: A Retrospective Study
by: Alotaibi M, et al.
Published: (2021-09-01)

QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
by: Sarah Grewal, et al.
Published: (2020-09-01)

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019
by: Arun R. Sridhar, MBBS, MPH, et al.
Published: (2020-08-01)

Chloroquine and hydroxychloroquine for COVID-19 treatment
by: Dwi Aris Agung Nugrahaningsih, et al.
Published: (2020-05-01)